Literature DB >> 10480881

Characterization of the Stat5 protease.

C Lee1, F Piazza, S Brutsaert, J Valens, I Strehlow, M Jarosinski, C Saris, C Schindler.   

Abstract

Immature myeloid cells have been shown to transduce signals through a carboxyl-terminally truncated isoform of Stat5. This functionally distinct signal transducer and activator of transcription isoform is generated through a unique protein-processing event. Evaluation of numerous cell lines has determined that there is a direct correlation between the expression of truncated Stat5 and protease activity. Moreover, protease activity is found only in the myeloid and not in lymphoid progenitors. To further characterize the protease small quantities have been purified to near homogeneity. Studies on this purified material indicate that the protease has an apparent molecular mass of approximately 25 kDa and is active over a wide range of pH values. The protease will also cleave both activated (i.e. tyrosine-phosphorylated) and inactivate Stat5. Although this activity is sensitive to phenylmethylsulfonyl fluoride, it is notably not sensitive to several other serine protease inhibitors. Additional studies have led to the identification of the unique site where the protease cleaves Stat5. Mutagenesis of this site renders Stat5 resistant to cleavage. Consistent with the model that Stat5 cleavage is important for early myeloid development, introduction of a "non-cleavable" isoform of Stat5 into FDC-P1 cells (a myeloid progenitor line) leads to significant phenotypic changes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480881     DOI: 10.1074/jbc.274.38.26767

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Stat transcription factors in mammary gland development and tumorigenesis.

Authors:  C J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 2.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

3.  Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.

Authors:  Sally A Litherland; Kristie M Grebe; Nicole S Belkin; Edward Paek; Jessica Elf; Mark Atkinson; Laurence Morel; Michael J Clare-Salzler; Marcia McDuffie
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

4.  Signal transduction activator of transcription 5 (STAT5) dysfunction in autoimmune monocytes and macrophages.

Authors:  S A Litherland; T X Xie; K M Grebe; A Davoodi-Semiromi; J Elf; N S Belkin; L L Moldawer; M J Clare-Salzler
Journal:  J Autoimmun       Date:  2005-03-23       Impact factor: 7.094

5.  Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation.

Authors:  M S Boosalis; R Bandyopadhyay; E H Bresnick; B S Pace; K Van DeMark; B Zhang; D V Faller; S P Perrine
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  STAT5 isoforms: controversies and clarifications.

Authors:  Haydeé L Ramos; John J O'Shea; Wendy T Watford
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

7.  Purification and identification of the STAT5 protease in myeloid cells.

Authors:  Björn Schuster; Lisa Hendry; Helen Byers; Steven F Lynham; Malcolm A Ward; Susan John
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

8.  Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.

Authors:  Kotaro Suzuki; Hiroshi Nakajima; Shin-Ichiro Kagami; Akira Suto; Kei Ikeda; Koichi Hirose; Takaki Hiwasa; Kiyoshi Takeda; Yasushi Saito; Shizuo Akira; Itsuo Iwamoto
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

9.  Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Authors:  Caroline Schoenherr; Katharina Wohlan; Iris Dallmann; Andreas Pich; Jan Hegermann; Arnold Ganser; Denise Hilfiker-Kleiner; Olaf Heidenreich; Michaela Scherr; Matthias Eder
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.